Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
4DMedical Ltd ( (AU:4DX) ) has shared an announcement.
4DMedical Ltd has announced the quotation of 56,112 ordinary fully paid securities on the ASX, effective from August 26, 2025. This move reflects the company’s ongoing efforts to enhance its market presence and operational capabilities, potentially impacting its industry positioning and offering new opportunities for stakeholders.
The most recent analyst rating on (AU:4DX) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd operates in the medical technology industry, focusing on innovative imaging solutions. The company specializes in developing advanced diagnostic tools for respiratory health, aiming to improve patient outcomes and streamline healthcare processes.
Average Trading Volume: 1,654,075
Technical Sentiment Signal: Buy
Current Market Cap: A$253.7M
See more insights into 4DX stock on TipRanks’ Stock Analysis page.